QDEL - Quidel more quick diagnosis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QDEL - Quidel more quick diagnosis

QDEL 24.35

+14.3%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Randy Atkins who wrote (621)	4/15/1997 1:52:00 AM
From: Randy Atkins	of 1693

FWIW, here is a question and answer lifted from Biotech Rumor Mill: "Q: Can anyone advise as to the merit of the patent infringement suit B-D has against Quidel? Is this just harrassment on B-D's part, or do they have a case?" "A: Presume it relates to the patent held by BD for lateral flow by particles ie colloidal gold strip tests which Quidel make. There are 2 significant patent suites for strip tests, one lot held by BD, the other by Unipath. Last year BD & Unipath agreed to recognise the patents each company held and go chasing after infringers. Quidel sales must have reached a point above the threshold level and triggered a response. Believe that Quidel haven't licensed the patents yet, now may be the time that they do so..." The above answer was posted anonymous, so appropriate caveats are in force... --Randy P.S.-- The above website has occasional posts concerning both protagonists.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next